The Patent Finder

Alzheon, Inc.

10 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2035
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due May 12, 2027
    The maintenance fee for Methods for Treating Neurological Disorders (US 10,471,029) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
  • 1 fee due Sep 17, 2027
    The maintenance fee for Compositions and Methods for Treating and Preventing Neurodegenerative Disorders (US 10,590,070) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

PatentTitleStatus Expires Confidence
US 10,471,029Methods for Treating Neurological Disorders
In force
 · High confidence
In forceHigh confidence
US 10,590,070Compositions and Methods for Treating and Preventing Neurodegenerative Disorders
In force
 · High confidence
In forceHigh confidence
US 11,053,192Compositions and Methods for Treating and Preventing Neurodegenerative Disorders
In force
 · High confidence
In forceHigh confidence
US 12,187,668Compositions and Methods for Treating and Preventing Neurodegenerative Disorders
In force
 · Low confidence
In forceLow confidence
US 11,191,742Methods of Treating Neurodegenerative Disorders in a Particular Population
In force
 · High confidence
In forceHigh confidence
US 11,077,095Methods for Treating Neurodegenerative Disorders
In force
 · High confidence
In forceHigh confidence
US 12,036,208Methods for Treating Neurodegenerative Disorders
In force
 · High confidence
In forceHigh confidence
US 12,083,082Methods for Treating Neurodegenerative Disorders
In force
 · High confidence
In forceHigh confidence
US 12,285,400Sulfopropanoic acid derivatives for treating neurodegenerative disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,788,734ALZ-801 for Use in Treating a COVID-19 Associated Neurological Symptom
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 4 abandoned

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited